Tag: clinical diagnostics market

More IVD Consolidation: DPC Sells to Siemens

CEO SUMMARY: It is a significant acquisition, and not just because Diagnostic Products Corporation has a major presence in immunodiagnostics. Siemens Medical Solutions is one of the dominant competitors in radiology. Its willingness to pony up almost $2 billion to enter the clinical diagnostics market signals a serious intent to develop services that support individualized

View Article

Proteomic Tests Poised For Clinical Market

CEO SUMMARY: Proteomics-based technology is developing rapidly. The strategic collaboration announced last month between Ciphergen Biosystems and Quest Diagnostics Incorporated is potentially worth $25 million. It is an expensive bet that next-generation proteomics tests soon to enter the clinical marketplace will provide high clinical utility and give physicians new diagnostic tools.

NEW PROTEOMIC-BASED TECHNOLOGIES ARE MOVING

View Article

Sigma-Aldrich, Ivax Diagnostics, i-STAT, Quest Diagnostics, Unilab

SIGMA-ALDRICH SELLS ITS EIA PRODUCT LINE TO IVAX DIAGNOSTICS
FOLLOWING ITS DECISION TO EXIT the clinical diagnostics market, Sigma-Aldrich, Inc. has sold its global enzyme immunoassay (EIA) product line to Ivax Diagnostics, Inc., based in Miami, Florida.

The sale occurred on May 15. Sigma-Aldrich, through its Sigma Diagnostics division, was selling EIA instruments and reagents produced by

View Article

Beckman Coulter Positions Itself For Biotech Testing Continuum

CEO SUMMARY: Here’s a little-known side to diagnostics giant Beckman Coulter Inc. Its efforts to expand into the fields of biomedical R&D and clinical research is a strategic shift designed to give it early access to promising technology that could be introduced into the clinical diagnostics marketplace. In this exclusive interview, John (Jack) Wareham, Chair,

View Article